C.I. MedicalLtd Past Earnings Performance
Past criteria checks 5/6
C.I. MedicalLtd has been growing earnings at an average annual rate of 6.4%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 10.4% per year. C.I. MedicalLtd's return on equity is 22.7%, and it has net margins of 9.9%.
Key information
6.4%
Earnings growth rate
6.4%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 10.4% |
| Return on equity | 22.7% |
| Net Margin | 9.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
C.I. MedicalLtd (TSE:3540) Has A Somewhat Strained Balance Sheet
Oct 24
C.I. Medical Co.,Ltd. (TSE:3540) Looks Just Right With A 25% Price Jump
Aug 15Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching
May 02Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)
Apr 14Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?
Mar 08Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year
Feb 18Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?
Jan 31
Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?
Jan 13Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?
Dec 26Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?
Dec 08Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?
Nov 20Revenue & Expenses Breakdown
How C.I. MedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 57,228 | 5,680 | 14,852 | 0 |
| 30 Jun 24 | 47,747 | 1,433 | 10,081 | 0 |
| 31 Mar 24 | 46,575 | 1,808 | 9,562 | 0 |
| 31 Dec 23 | 45,628 | 2,082 | 9,004 | 0 |
| 30 Sep 23 | 45,071 | 2,162 | 8,452 | 0 |
| 30 Jun 23 | 44,125 | 2,219 | 8,132 | 0 |
| 31 Mar 23 | 43,473 | 2,173 | 7,931 | 0 |
| 31 Dec 22 | 42,891 | 2,521 | 7,681 | 0 |
| 30 Sep 22 | 42,073 | 2,709 | 7,533 | 0 |
| 30 Jun 22 | 41,754 | 2,798 | 7,358 | 0 |
| 31 Mar 22 | 41,142 | 2,815 | 7,242 | 0 |
| 31 Dec 21 | 41,205 | 2,820 | 7,081 | 0 |
| 30 Sep 21 | 41,500 | 3,182 | 7,041 | 0 |
| 30 Jun 21 | 40,833 | 3,334 | 6,872 | 0 |
| 31 Mar 21 | 39,593 | 3,309 | 6,622 | 0 |
| 31 Dec 20 | 37,393 | 2,920 | 6,590 | 0 |
| 30 Sep 20 | 33,251 | 2,263 | 6,260 | 0 |
| 30 Jun 20 | 31,964 | 1,924 | 6,093 | 0 |
| 31 Mar 20 | 30,265 | 1,608 | 5,959 | 0 |
| 31 Dec 19 | 28,763 | 1,505 | 5,653 | 0 |
| 30 Sep 19 | 28,876 | 1,571 | 5,475 | 0 |
| 30 Jun 19 | 26,898 | 1,345 | 5,268 | 0 |
| 31 Mar 19 | 26,484 | 1,414 | 5,112 | 0 |
| 31 Dec 18 | 25,806 | 1,329 | 4,945 | 0 |
| 30 Sep 18 | 24,892 | 1,358 | 4,757 | 0 |
| 30 Jun 18 | 24,323 | 1,458 | 4,523 | 0 |
| 31 Mar 18 | 23,336 | 1,445 | 4,263 | 0 |
| 31 Dec 17 | 22,830 | 1,539 | 4,088 | 0 |
| 30 Sep 17 | 21,999 | 1,486 | 3,932 | 0 |
| 30 Jun 17 | 21,440 | 1,497 | 3,881 | 0 |
| 31 Mar 17 | 20,887 | 1,390 | 3,794 | 0 |
| 31 Dec 16 | 20,334 | 1,282 | 3,706 | 0 |
| 31 Dec 15 | 18,145 | 1,088 | 3,079 | 0 |
| 31 Dec 14 | 16,084 | 901 | 2,712 | 0 |
Quality Earnings: 3540 has a large one-off gain of ¥4.6B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 3540's current net profit margins (9.9%) are higher than last year (4.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3540's earnings have grown by 6.4% per year over the past 5 years.
Accelerating Growth: 3540's earnings growth over the past year (162.7%) exceeds its 5-year average (6.4% per year).
Earnings vs Industry: 3540 earnings growth over the past year (162.7%) exceeded the Healthcare industry 8.3%.
Return on Equity
High ROE: 3540's Return on Equity (22.7%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 05:46 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C.I. Medical Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Takahiro Mori | Daiwa Securities Co. Ltd. |
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Takahiro Mori | Mizuho Securities Co., Ltd. |